Sara Pellegrino

Sara Pellegrino, IRC, currently serves as the Senior Vice President of Investor Relations & Corporate Communications at Iovance Biotherapeutics, Inc., a position held since January 2020. Prior to this role, Sara was the Vice President of Investor Relations & Public Relations at Amicus Therapeutics from March 2011 to January 2020. Earlier career experiences include serving as Senior Vice President at The Ruth Group and Senior Associate in Biotechnology at Thomson Reuters. Sara began a financial career as a Futures Trader at Goldenberg Hehmeyer Trading Co Ltd. Sara Pellegrino holds a Bachelor of Science degree with a double major in Finance and Marketing from Tulane University, completed in 2002.